添加微信 添加微信
添加微信
首页: 全球医药政策

泰国-Asia Global Research (AGR)

时间:2021-10-21 16:17:55 来源:康安医药咨询 作者:康安医药咨询

AGR is a subsidiary of Bumrungrad International Hospital Public Company Limited (SET:BH), based in Bangkok, Thailand. Through its CRO and SMO business segments, the company offers a broad range of Phase I to IV clinical trials and staffing. AGR will help establish clinical trial in Southeast Asia, with its diverse patient populations, as an ideal location for rigorous, insightful and cost-effective outsourcing clinical research. AGR’s trial management capabilities include establishing and monitoring trials in Thailand. The Clinical Research Organization (CRO) is staffed with research professionals who possess many years of experience managing clinical trials in the global environment. This highly trained group is fully capable of managing complete development programs or any individual service required by a sponsor. The Site Management Organization (SMO) is made up of personnel who use their years of experience in conducting site studies for the international pharmaceutical industry. This staff evaluates and recruits hospital and clinics which meet the ICH-GCP standards required for producing rapid enrolment and quality data.

Phone: 66, (0), 2011, 5126 Fax: 66, (0), 2011, 5127 E-mail: info@agr-cro.com
Web: http://www.asiaglobalresearch.com
Add:BRO Building, 3241 Rama IV Rd., Klong Ton, Klong Toey, Bangkok 10110

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章